MeSH Review:
Narcolepsy
- Reduced number of hypocretin neurons in human narcolepsy. Thannickal, T.C., Moore, R.Y., Nienhuis, R., Ramanathan, L., Gulyani, S., Aldrich, M., Cornford, M., Siegel, J.M. Neuron (2000)
- Disordered growth hormone and prolactin secretion in primary disorders of sleep. Clark, R.W., Schmidt, H.S., Malarkey, W.B. Neurology (1979)
- Selegiline in the treatment of narcolepsy. Hublin, C., Partinen, M., Heinonen, E.H., Puukka, P., Salmi, T. Neurology (1994)
- Sleep-related eating disorders: polysomnographic correlates of a heterogeneous syndrome distinct from daytime eating disorders. Schenck, C.H., Hurwitz, T.D., Bundlie, S.R., Mahowald, M.W. Sleep. (1991)
- Narcolepsy caused by acute disseminated encephalomyelitis. Gledhill, R.F., Bartel, P.R., Yoshida, Y., Nishino, S., Scammell, T.E. Arch. Neurol. (2004)
- Input of orexin/hypocretin neurons revealed by a genetically encoded tracer in mice. Sakurai, T., Nagata, R., Yamanaka, A., Kawamura, H., Tsujino, N., Muraki, Y., Kageyama, H., Kunita, S., Takahashi, S., Goto, K., Koyama, Y., Shioda, S., Yanagisawa, M. Neuron (2005)
- Distinct narcolepsy syndromes in Orexin receptor-2 and Orexin null mice: molecular genetic dissection of Non-REM and REM sleep regulatory processes. Willie, J.T., Chemelli, R.M., Sinton, C.M., Tokita, S., Williams, S.C., Kisanuki, Y.Y., Marcus, J.N., Lee, C., Elmquist, J.K., Kohlmeier, K.A., Leonard, C.S., Richardson, J.A., Hammer, R.E., Yanagisawa, M. Neuron (2003)
- Treatment of narcolepsy with L-tyrosine: double-blind placebo-controlled trial. Elwes, R.D., Crewes, H., Chesterman, L.P., Summers, B., Jenner, P., Binnie, C.D., Parkes, J.D. Lancet (1989)
- Hypersomnia in bipolar depression: a comparison with narcolepsy using the multiple sleep latency test. Nofzinger, E.A., Thase, M.E., Reynolds, C.F., Himmelhoch, J.M., Mallinger, A., Houck, P., Kupfer, D.J. The American journal of psychiatry. (1991)
- The clinical spectrum of narcolepsy and idiopathic hypersomnia. Aldrich, M.S. Neurology (1996)
- The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Lin, L., Faraco, J., Li, R., Kadotani, H., Rogers, W., Lin, X., Qiu, X., de Jong, P.J., Nishino, S., Mignot, E. Cell (1999)
- Letter: Narcolepsy: REM sleep suppression by L-dopa. Gilbert, J.C., Willer, J.C., Bernheim-Chaltelain, C., Ecoffet, M., Jaillon, P. N. Engl. J. Med. (1976)
- A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Peyron, C., Faraco, J., Rogers, W., Ripley, B., Overeem, S., Charnay, Y., Nevsimalova, S., Aldrich, M., Reynolds, D., Albin, R., Li, R., Hungs, M., Pedrazzoli, M., Padigaru, M., Kucherlapati, M., Fan, J., Maki, R., Lammers, G.J., Bouras, C., Kucherlapati, R., Nishino, S., Mignot, E. Nat. Med. (2000)
- The neurobiology of narcolepsy. Aldrich, M.S. Trends Neurosci. (1991)
- Acetylcholine and the regulation of REM sleep: basic mechanisms and clinical implications for affective illness and narcolepsy. Shiromani, P.J., Gillin, J.C., Henriksen, S.J. Annu. Rev. Pharmacol. Toxicol. (1987)
- Role of central alpha-1 adrenoceptors in canine narcolepsy. Mignot, E., Guilleminault, C., Bowersox, S., Rappaport, A., Dement, W.C. J. Clin. Invest. (1988)
- Deprenyl in narcolepsy. Schachter, M., Price, P.A., Perkes, J.D. Lancet (1979)
- Propranolol in the treatment of narcolepsy. Kales, A., Soldatos, C.R., Cadieux, R., Bixler, E.O., Tan, T.L., Scharf, M.B. Ann. Intern. Med. (1979)
- Sleep, feeding, and neuropeptides: roles of orexins and orexin receptors. Mieda, M., Yanagisawa, M. Curr. Opin. Neurobiol. (2002)
- A narcolepsy susceptibility locus maps to a 5 Mb region of chromosome 21q. Dauvilliers, Y., Blouin, J.L., Neidhart, E., Carlander, B., Eliaou, J.F., Antonarakis, S.E., Billiard, M., Tafti, M. Ann. Neurol. (2004)
- HLA class II genes associated with REM sleep behavior disorder. Schenck, C.H., Garcia-Rill, E., Segall, M., Noreen, H., Mahowald, M.W. Ann. Neurol. (1996)
- Identification and functional analysis of mutations in the hypocretin (orexin) genes of narcoleptic canines. Hungs, M., Fan, J., Lin, L., Lin, X., Maki, R.A., Mignot, E. Genome Res. (2001)
- Brain neurotransmitter changes in human narcolepsy. Kish, S.J., Mamelak, M., Slimovitch, C., Dixon, L.M., Lewis, A., Shannak, K., DiStefano, L., Chang, L.J., Hornykiewicz, O. Neurology (1992)
- Glucose hypometabolism of hypothalamus and thalamus in narcolepsy. Joo, E.Y., Tae, W.S., Kim, J.H., Kim, B.T., Hong, S.B. Ann. Neurol. (2004)
- Treatment with immunosuppressive and anti-inflammatory agents delays onset of canine genetic narcolepsy and reduces symptom severity. Boehmer, L.N., Wu, M.F., John, J., Siegel, J.M. Exp. Neurol. (2004)
- Comparison of the psychosocial effects of epilepsy and narcolepsy/cataplexy: a controlled study. Broughton, R.J., Guberman, A., Roberts, J. Epilepsia (1984)
- DLA-DQB1 alleles and bone marrow transplantation experiments in narcoleptic dogs. Wagner, J.L., Storb, R., Storer, B., Mignot, E. Tissue Antigens (2000)
- Dopamine D2-receptors in human narcolepsy: a SPECT study with 123I-IBZM. Hublin, C., Launes, J., Nikkinen, P., Partinen, M. Acta neurologica Scandinavica. (1994)
- Hypocretin/orexin, sleep and narcolepsy. Hungs, M., Mignot, E. Bioessays (2001)
- Correlation of psycho-neuroendocrine-immune (PNI) gene expression with symptoms of acute infectious mononucleosis. Vernon, S.D., Nicholson, A., Rajeevan, M., Dimulescu, I., Cameron, B., Whistler, T., Lloyd, A. Brain Res. (2006)
- Significant association of a single nucleotide polymorphism in the tumor necrosis factor-alpha (TNF-alpha) gene promoter with human narcolepsy. Hohjoh, H., Nakayama, T., Ohashi, J., Miyagawa, T., Tanaka, H., Akaza, T., Honda, Y., Juji, T., Tokunaga, K. Tissue Antigens (1999)
- A deletion in the second exon of an HLA-DRB1 allele found in a DR2-negative narcolepsy patient. Roushdy, J., Santoso, S., Kalb, R., Meier-Ewert, K., Albert, E.D., Mueller-Eckhardt, G. Hum. Immunol. (1993)
- Increased serotonin receptor availability in human sleep: evidence from an [18F]MPPF PET study in narcolepsy. Derry, C., Benjamin, C., Bladin, P., le Bars, D., Tochon-Danguy, H., Berkovic, S.F., Zimmer, L., Costes, N., Mulligan, R., Reutens, D. Neuroimage (2006)
- Efficacy of gamma-hydroxybutyrate versus placebo in treating narcolepsy-cataplexy: double-blind subjective measures. Scrima, L., Hartman, P.G., Johnson, F.H., Hiller, F.C. Biol. Psychiatry (1989)
- REM changes in narcolepsy with selegiline. Reinish, L.W., MacFarlane, J.G., Sandor, P., Shapiro, C.M. Sleep. (1995)
- The effects of gamma-hydroxybutyrate on the sleep of narcolepsy patients: a double-blind study. Scrima, L., Hartman, P.G., Johnson, F.H., Thomas, E.E., Hiller, F.C. Sleep. (1990)